• Start date:
  • 14 November 2019
  • Duration:
  • 1 day
  • Working as:
  • Medical specialist, (Academic) researcher

Accreditations

  • NVKC:
  • 6

How do laboratory specialists and medical laboratories contribute to better patient outcome and more effective treatment? During this symposium we define health and disease at a molecular level on the basis of Clinical Proteomics. The potential of precision diagnostics is also examined. Do you want to know more? Please register timely via the registration link on this page.

Clinical evidence
To contribute to patient care in an efficient and effective way, it is important to rationalize the clinical needs. We will address the clinical needs question during the symposium. In addition to this, we will discuss the positioning of medical tests in clinical care pathways and to the generation of clinical evidence. Another important objective of the symposium is to bring clinical chemistry laboratory specialists together with other stakeholders of the biomarker - medical test pipeline.

Learning objectives:

  • Applying a structured questionnaire for identifying unmet clinical needs in laboratory medicine, in line with 21st century precision medicine demands;
  • Demonstrating (multiplex) test selection and deducing future clinical pathways based on unmet needs;
  • Guiding test evaluation according to the EFLM Test Evaluation framework;
  • Demonstrating young trainees in laboratory medicine how to develop medical leadership skills in focus areas of innovation, enabling technology and/or data science.
  • Identifying a feasible role as end-user in the biomarker-test development pipeline, in line with the abilities in your hospital setting
  • Developing network skills for collaboration between clinicians, laboratory professionals, IVD-industry and basic scientists.

Intended target population:

  • Laboratory Specialist Trainees in Clinical Chemistry and Hematology
  • Laboratory Specialists in Clinical Chemistry and Hematology
  • Translational Researchers, clinicians and IVD-manufacturers interested and involved in the biomarker-test pipeline
  • Pathologists
  • Urologists
  • Nephrologists
  • Oncologists
  • Clinical Geneticists

Organization

The symposium is a collaboration between Boerhaave Continuing Medical Education and the Department of Clinical Chemistry and Laboratory Medicine of the Leiden University Medical Center (LUMC). The lectures will be given by renowned speakers in the field of Test Evaluation, Test Standardization and Clinical Proteomics.

 

This symposium is sponsered by Roche Diagnostics Nederland B.V and Sysmex Belgium N.V.

08:30 Registration
09.30 Welcome
Prof. dr. Christa Cobbaert
  Basics and key components of the EFLM Test Evaluation framework
Chair: Prof. dr. Christa Cobbaert
09.40 Essentials of the EFLM Test Evaluation framework in the era of IVDR 2017/746
Prof. dr. Patrick Bossuyt
  Applying the basics for test (panel) selection and clinical pathway redesign
Chairs: Prof. dr. Patrick Bossuyt and Prof. dr. Christa Cobbaert
10.15 The nephrologist viewpoints regarding desirable urine diagnostic support & clinical pathways for reducing kidney injury in secondary and tertiary care hospitals
Prof. dr. Hans de Fijter and Dr. Darius Soonawala
11.00 The researcher's rationale for selecting a multiplexed biomarker panel for kidney injury based on clinical chemistry needs
Drs. Tirsa van Duijl
11.25 Predefining clinical performance specifications for potentially useful tests for colorectal cancer screening, as addition to the current iFOBT
Dr. Wilbert van den Hout
11.50 Interactive: Questions and answers
Host: Prof. dr. Christa Cobbaert
12.00 Lunch
  Exploring the potential of (glyco-)proteoforms as future medical tests by means of enabling technology
Chairs: Prof. dr. Andy Hoofnagle and Dr. Renee Ruhaak
13.00 Generating a New Hypothesis: Targeted Proteomics, Apolipoprotein L1, and Chronic Kidney Disease
Prof. dr. Andy Hoofnagle
13.30 Understanding the antithrombin measurand using an MS-based antithrombin proteoform method
Dr. Renee Ruhaak
14.00 An additional layer of clinical information beyond the imperfect total PSA: challenges and opportunities for GLY-PSA?
Dr. Yuri van der Burgt
14.30 Coffee break
  Adopting the metrological traceability and commutability concepts into quantitative proteomics applications right from the start: the serum apolipoprotein profile example
Chairs: Prof. Andy Hoofnagle and Prof. dr. Christa Cobbaert
14.50 Confounded Lp(a) test results masked clinical utility of Lp(a) test for decades
Prof. dr. Gerhard Kostner
15.20 The relevance of developing an IFCC MS-based multiplex apoprotein profile method addressing unmet CVD needs
Prof. dr. Uta Ceglarek
15.45 Development of SI-traceable primary reference materials for quantitative proteomics of serum apolipoproteins
Dr. Vincent Delatour
16.10 Development of SI-traceable and commutable secondary reference materials for quantitative proteomics of serum apolipoproteins
Dr. Liesbet Deprez
16.30 Interactive: Questions and answers
Chairs: Prof. Andy Hoofnagle and host: Prof. dr. Christa Cobbaert
16.45 Reception

   

  

 

 

Prof. dr. P.M. Bossuyt
Dr. Y.E.M. van der Burgt
Prof. dr. U. Ceglarek
Prof. dr. C.M. Cobbaert
Klinisch chemicus, LUMC
Dr. V. Delatour
Dr. L. Deprez
Drs. T.T. van Duijl
Prof. dr. J.W. de Fijter
Interne Geneeskunde, LUMC
Prof. dr. A. Hoofnagle
Dr. W.B. van den Hout
Prof. dr. G. Kostner
Dr. L.R. Ruhaak
Dr. D. Soonawala
LUMC
Rijnsburgerweg 10, 2333 AA Leiden

Building: LUMC Poortgebouw Zuid

Extra information: 1st floor

Location: Leiden

Regular fee € 150,-
Trainee fee € 100,- (€50,- discount)